US Broker Ratings

DaVita Inc. (DVA) Stock Analysis: Insights into a 19% Potential Upside for Healthcare Investors

DaVita Inc. (NYSE: DVA), a leading provider of kidney dialysis services in the United States, is catching the eye of investors with its notable potential upside. Currently trading at $121.35,..

Henry Schein, Inc. (HSIC) Investor Outlook: Navigating Growth Opportunities in Healthcare Distribution

Henry Schein, Inc. (NASDAQ: HSIC), a stalwart in the healthcare sector, has carved a niche in the medical distribution industry. With a market capitalization of $9.28 billion, the company stands..

HCA Healthcare, Inc. (HCA) Stock Analysis: Navigating a $113 Billion Healthcare Giant with Strategic Growth

HCA Healthcare, Inc. (NYSE: HCA), a behemoth in the medical care facilities sector, stands as a pivotal player in the United States healthcare landscape. With a staggering market capitalization of..

Chemed Corp (CHE) Stock Analysis: A 33.53% Potential Upside Amidst Strong Analyst Support

Chemed Corp (NYSE: CHE), a veteran player in the healthcare sector, operates primarily through its VITAS and Roto-Rooter segments, offering a diverse range of services from hospice care to plumbing..

Tempus AI, Inc. (TEM) Stock Analysis: Evaluating the 29.47% Potential Upside for Investors

Tempus AI, Inc. (NASDAQ: TEM), a healthcare technology company headquartered in Chicago, Illinois, is making waves in the health information services industry with its innovative diagnostic and data solutions. With..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Unpacking the 21.31% Potential Upside for Investors

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a burgeoning player in the biopharmaceutical sector, has been making significant strides with its innovative treatments for central nervous system disorders. With a current market..

Option Care Health (OPCH) Stock Analysis: A Promising 9.67% Upside for Investors in the Healthcare Sector

Option Care Health, Inc. (NASDAQ: OPCH) is making waves in the healthcare sector with its robust home and alternate site infusion services. Headquartered in Bannockburn, Illinois, the company operates within..

Cardinal Health, Inc. (CAH) Stock Analysis: Evaluating a Healthcare Giant with a 9.29% Potential Upside

Cardinal Health, Inc. (NYSE: CAH), a prominent player in the healthcare sector, is a powerhouse in the medical distribution industry with a significant market cap of $47.09 billion. Headquartered in..

Viatris Inc. (VTRS) Stock Analysis: Navigating a 6.82% Potential Upside in the Healthcare Market

Viatris Inc. (NASDAQ: VTRS), a prominent player in the healthcare sector, presents an intriguing investment opportunity with its potential upside of 6.82%, according to recent analyst ratings. As a company..

Repligen Corporation (RGEN) Investor Outlook: Analyzing a 19.7% Potential Upside in the Bioprocessing Sector

Repligen Corporation (NASDAQ: RGEN) stands as a significant player in the healthcare sector, specifically within the medical instruments and supplies industry. With its headquarters in Waltham, Massachusetts, Repligen focuses on..

Sanofi (SNY) Stock Analysis: Attractive 23.52% Upside Potential Amid Strong Analyst Support

Sanofi (SNY), a leading player in the healthcare sector, operates within the Drug Manufacturers – General industry. Headquartered in Paris, France, Sanofi boasts a robust market capitalization of $118.82 billion,..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Evaluating Growth in Sleep Apnea Solutions

Inspire Medical Systems, Inc. (NASDAQ: INSP), a pioneering force in the healthcare sector, has emerged as a key player in the medical devices industry with its innovative solutions for obstructive..

The Ensign Group, Inc. (ENSG) Stock Analysis: Is a 17.98% Upside Within Reach?

The Ensign Group, Inc. (NASDAQ: ENSG), a prominent player in the healthcare sector, has been catching the eye of investors with its robust performance and promising forecasts. With a market..

Gilead Sciences (GILD) Stock Analysis: A Closer Look at a 9.63% Potential Upside in the Biopharma Giant

Gilead Sciences, Inc. (NASDAQ: GILD), a formidable player in the biopharmaceutical landscape, continues to capture the attention of investors with its robust portfolio of medicines addressing unmet medical needs globally...

Merit Medical Systems (MMSI) Stock Analysis: Exploring an 18% Upside Potential in the Healthcare Sector

Investors eyeing the healthcare sector may find Merit Medical Systems, Inc. (NASDAQ: MMSI) an intriguing prospect, particularly given its potential upside of over 18%, as indicated by current analyst ratings...

STERIS plc (STE) Stock Analysis: Exploring a Promising 11.85% Upside Potential

STERIS plc (NYSE: STE), a prominent entity in the healthcare sector, is making waves in the medical devices industry with its infection prevention products and services. Headquartered in Mentor, Ohio,..

McKesson Corporation (MCK) Stock Analysis: Unlocking a 15% Upside Potential in the Healthcare Sector

McKesson Corporation (NYSE: MCK) stands as a formidable player in the healthcare sector, with a particular focus on medical distribution. With a market cap surpassing $101 billion, this Irving, Texas-based..

Genmab A/S (GMAB) Stock Analysis: A Biotechnology Powerhouse with 20.77% Upside Potential

Genmab A/S (NASDAQ: GMAB), a frontrunner in the biotechnology sector, is capturing the attention of investors with its robust pipeline of antibody-based cancer treatments and a promising potential upside of..

BeOne Medicines Ltd. (ONC): Consensus Signals 25.84% Upside Amid Robust Oncology Pipeline

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, is making waves in the healthcare industry with its strong focus on oncology treatments. Headquartered in Basel, Switzerland, this..

Charles River Laboratories (CRL) Stock Analysis: Navigating Challenges with Strategic Collaborations

Charles River Laboratories International, Inc. (NYSE: CRL), a prominent player in the healthcare sector specializing in diagnostics and research, presents a mixed yet intriguing landscape for investors. With a market..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds